Skip to main content

ResMed| ownership: holders and insider trading

  • RMD · NYSE
  • Medical devices
  • Health Care Equipment
  • S&P 500
$240.13+0.81%Close 17 Nov 2026 · Market value $33.61B

As filed, its directors and officers own 0.6% of the shares (proxy statement, 22 Sep 2026); 885 institutional managers reported holding 71.1% at 30 Jun 2026. Over the last twelve months, insiders sold $20.16M of shares on the open market, $20.16M of it under 10b5-1 plans set in advance, and bought none.

From the company's proxy statement, each holder's latest Schedule 13D or 13G, the institutional managers' quarterly 13F reports and the insiders' Form 4 filings. A percentage is shown as filed; one marked * is worked out here from the shares outstanding.

Largest holders

HolderTypeSharesOf the companySourceAs of
BlackRock, Inc.Holder12.8M9.09%Proxy statement22 Sep 2026
Vanguard Capital ManagementHolder12.0M8.21%Schedule 13G31 Mar 2026
AustralianSuper Pty LtdHolder8.3M5.88%Proxy statement22 Sep 2026
Vanguard Portfolio Management LLCHolder7.9M5.61%Proxy statement22 Sep 2026
State StreetInstitution6.7M4.75%*Form 13F30 Jun 2026
Geode Capital ManagementInstitution4.4M3.09%*Form 13F30 Jun 2026
BNYInstitution4.2M2.98%*Form 13F30 Jun 2026
First Trust Advisors LPInstitution2.3M1.62%*Form 13F30 Jun 2026
UBSInstitution2.1M1.53%*Form 13F30 Jun 2026
InvescoInstitution2.1M1.47%*Form 13F30 Jun 2026
Morgan StanleyInstitution1.9M1.37%*Form 13F30 Jun 2026
Northern TrustInstitution1.7M1.21%*Form 13F30 Jun 2026
Nordea Investment Management ABInstitution1.4M0.99%*Form 13F30 Jun 2026
Deutsche BankInstitution1.3M0.94%*Form 13F30 Jun 2026
Swedbank ABInstitution1.3M0.91%*Form 13F30 Jun 2026
Charles SchwabInstitution1.2M0.87%*Form 13F30 Jun 2026
Goldman SachsInstitution1.2M0.83%*Form 13F30 Jun 2026
Arrowstreet Capital, Limited PartnershipInstitution1.1M0.80%*Form 13F30 Jun 2026
Dimensional Fund AdvisorsInstitution1.1M0.80%*Form 13F30 Jun 2026
Legal & GeneralInstitution943K0.67%*Form 13F30 Jun 2026

Insider transactions latest 25

InsiderDateTransactionSharesPriceValue
Farrell Michael J. · Chairman and CEO · Director11 Nov 2026Shares withheld for tax−3.5K$234.11$811.4K
Farrell Michael J. · Chairman and CEO · Director11 Nov 2026Shares withheld for tax−2.2K$234.11$517.3K
Farrell Michael J. · Chairman and CEO · Director11 Nov 2026Shares withheld for tax−2.4K$234.11$570.3K
Bloomer Aaron · Chief Financial Officer11 Nov 2026Shares withheld for tax−1.1K$234.11$256.4K
FARRELL PETER C · Director11 Nov 2026Shares withheld for tax−169$234.11$39.60K
De Witte Jan · Director11 Nov 2026Shares withheld for tax−60$234.11$14.04K
Gill Harjit · Director11 Nov 2026Shares withheld for tax−36$234.11$8.36K
Rider Michael J · Global General Counsel11 Nov 2026Shares withheld for tax−547$234.11$128.2K
Rider Michael J · Global General Counsel11 Nov 2026Shares withheld for tax−499$234.11$116.7K
Rider Michael J · Global General Counsel11 Nov 2026Shares withheld for tax−724$234.11$169.6K
Rider Michael J · Global General Counsel11 Nov 2026Shares withheld for tax−173$234.11$40.50K
Farrell Michael J. · Chairman and CEO · Director9 Nov 2026Option exercise+683$146.34$99.95K
Farrell Michael J. · Chairman and CEO · Director9 Nov 2026Option exercise+4.3K$146.34$630.7K
Farrell Michael J. · Chairman and CEO · Director9 Nov 2026Open-market sale (10b5-1 plan)−5.0K$235.35$1.18M
Rider Michael J · Global General Counsel23 Oct 2026Open-market sale (10b5-1 plan)−400$255.00$102.0K
Farrell Michael J. · Chairman and CEO · Director7 Oct 2026Option exercise+5.0K$146.34$730.4K
Farrell Michael J. · Chairman and CEO · Director7 Oct 2026Open-market sale (10b5-1 plan)−5.0K$226.33$1.13M
Farrell Michael J. · Chairman and CEO · Director8 Sep 2026Option exercise+5.0K$146.34$730.4K
Farrell Michael J. · Chairman and CEO · Director8 Sep 2026Open-market sale (10b5-1 plan)−5.0K$222.44$1.11M
FARRELL PETER C · Director2 Sep 2026Open-market sale (10b5-1 plan)−970$234.73$227.7K
Leong Justin · Chief Product Officer14 Aug 2026Grant or award+6.5K——
Rider Michael J · Global General Counsel14 Aug 2026Grant or award+3.2K——
Farrell Michael J. · Chairman and CEO · Director14 Aug 2026Grant or award+13.5K——
Bloomer Aaron · Chief Financial Officer14 Aug 2026Grant or award+9.1K——
Farrell Michael J. · Chairman and CEO · Director7 Aug 2026Option exercise+5.0K$146.34$730.4K

Form 4 filings since 17 Nov 2024: purchases and sales, grants, option exercises and shares withheld for tax. Gifts and other transfers are left out.

RMD in the terminal

Holders over eight quarters by family, every Form 4 and Form 144 back two years, and alerts on insider buying.